Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trial

作者：Jie Lin, Yuan Ji, Gaopin Wang, Xueping Ma, Zhuhua Yao, Xuebin Han, Jie Chen, Jiyan Chen, Wei Huang, Guangma Xu, Daoquan Peng, Peishi Yan, Ping Qiao, Yong‐Ming He, Yi‐Da Tang, Minghui Wang, Mengqi Zhang, Jianjun Yu, Hao Yu, Changsheng Ma · 发表于：Atherosclerosis · 年份：2025 · DOI：10.1016/j.atherosclerosis.2025.119120 · 被引用次数：10 · 研究领域：Lipoproteins and Cardiovascular Health、Cholesterol and Lipid Metabolism、Diabetes, Cardiovascular Risks, and Lipoproteins